Skip to main content

Table 1 Characteristics of the HCC patients in our local cohort. Patients in our study had been previously diagnosed with HCC, experienced recurrence following adjuvant chemotherapy, and underwent postoperative anti-angiogenesis targeted drugs combined with immunotherapy treatment subsequent to relapse. BMI, body mass index; PD, progressive disease; PR, partial response; SD, stable disease

From: The impact of an RNA-binding protein group on regulating the RSPO-LGR4/5-ZNRF3/RNF43 module and the immune microenvironment in hepatocellular carcinoma

Characters

Cases (N = 28,%)

Age (range)

Sex

Male

Female

56 (32 ~ 76)

27 (96.4%)

1 (3.6%)

BMI

< 18.5

18.5 ~ 23.9

24.0 ~ 27.9

≥ 28.0

1 (3.5%)

12 (42.9%)

10 (35.7%)

5 (17.9)

Hepatitis B

Yes

No

24 (85.7%)

4 (14.3%)

Liver Cirrhosis

Yes

No

8 (28.6%)

20 (71.4%)

Alcoholic History

Yes

No

7 (25.0%)

21 (75.0%)

RECIST

PR

SD

PD

6 (21.4%)

17 (60.7%)

5 (17.9%)